CD274 and colorectal cancer: Current biomarkers for anti-PD1 in colorectal cancer, MSI/MSS, TMB, PDL1, and POLE/POLD1 mutation, share the same notion that anti-PD1 resistance is dominantly caused by one homogenous factor of an insufficient amount of CD8+ T-cell infiltration.